DENVER, April 20, 2015 /PRNewswire/ -- Med-X, Inc. announced today the appointments of Allan L. Kurtz D.O. and Morton I. Hyson M.D. to its Board of Directors.
"Dr. Kurtz's great deal of knowledge and experience in the area of internal medicine and pain management and Dr. Hyson's expertise in Neurology will play pivotal roles as our Company matures in the Medical Marijuana arena," states Med-X, Inc.'s founder and Chief Operating Officer, Matthew Mills.
"Our long term mission to cultivate multiple strains of organic Medical Marijuana for patient care is well underway in our new cooperative patient test facility. It has been recognized that Medical Marijuana being dispensed through a wide range of dispensaries nationally is completely unregulated and has been found, in many instances, that patients are receiving Medical Marijuana that is riddled with various pesticides and mold. This is the reason why our mission is so important," states Mills. "In order for the medical community to embrace and to confidently recommend the use of Medical Marijuana, physicians expect certain safety standards to be implemented and adhered to. Here at Med-X, Inc. we have taken great pride and exerted extreme diligence to offer a toxin free alternative for the community and the medical providers," states Med-X, Inc. Chief Executive Officer David E. Toomey D.O.
From April 20 thru April 22, 2015, Med-X, Inc. management team will be attending and showcasing the Company at the Marijuana Investor Summit in Denver, Colorado.
About Med-X, Inc.
Med-X, Inc. is a Nevada corporation formed in February 2014 to cultivate and support the fast paced emerging Cannabis industry segment such as compound identification and extraction of the identified Cannabidiol (CBD) compounds for the present medical industry demand. The Company also plans to create and publish high quality Cannabis industry media content through the Company's online media platform, www.marijuanatimes.org to generate revenue from advertisers as well as sell industry related merchandise to patients and consumers. The Company is also gearing up to supply products to the Cannabis agricultural and provisioning industries through manufacturing partnerships.
For more information regarding Med-X, Inc., email [email protected] or call 818-349-2870.
SOURCE Med-X, Inc.